Pain and Regional Anesthesia
Plastic Change of N-type Ca Channel Expression after Preconditioning Is Responsible for Prostaglandin E2-induced Long-lasting Allodynia
Yokoyama, Kazuaki M.D.*; Kurihara, Takashi Ph.D.†; Makita, Koshi M.D., Ph.D.‡; Tanabe, Tsutomu Ph.D.§
Background: Although considerable evidence indicates neuronal Ca channels play significant roles in pain perception, their possible importance in hypersensitization after acute inflammation has not been investigated.
: Using carrageenan for inducing hypersensitization, the authors investigated the analgesic effects of intrathecally administered N- and P/Q-type channel blockers, ω-conotoxin GVIA and ω-agatoxin IVA, respectively, and also examined the level of N-type channel expression.
: Acute inflammation, produced by carrageenan injection in a rat hind paw, caused mechanical hypersensitivity that resolved within several days. Injection of prostaglandin E2
into the same hind paw after resolution caused a markedly prolonged mechanical allodynia lasting more than 4 h. Similar but less potent prolonged allodynia was also induced in the contralateral hind paws. Intrathecal administration of ω-conotoxin GVIA (0.03–0.3 μg) produced dose-dependent inhibition of the allodynia in both control and carrageenan-preconditioned rats. However, the potency of ω-conotoxin GVIA was significantly lower in carrageenan-preconditioned paws than in those in the contralateral and saline-preconditioned paws. In contrast, ω-agatoxin IVA (0.01–0.1 μg) did not reduce the allodynia. Significant up-regulation of N-type channel expression was observed in both dorsal root ganglia and the spinal cord ipsilateral to the carrageenan-preconditioned hind paw.
Conclusions: The results suggest an aggravating role of the N-type channel in pain sensation and a selective plastic change of this channel expression that could underlie the mechanism of hypersensitization after acute inflammation.
SENSITIZATION of the central and peripheral nervous system is thought to be responsible for abnormal sensation, such as allodynia and hyperalgesia. Although considerable efforts have been made in elucidating the physiologic bases of pathologic pain, the cellular changes underlying the sensitization after inflammation of peripheral tissues remains unclear. 1,2
It has been suggested that the plastic change of nociceptive neurotransmission and/or modulatory systems during the acute inflammatory pain state may be important mechanisms in the development of chronic inflammatory pain, because these pain states follow an episode of acute inflammation. 3
In the experimental recurrent inflammation models that may represent human painful joint disorders, it is suggested that the response of the second inflammation is enhanced by the sensitization of the nervous system after resolution of the first inflammation. 4,5
Therefore, it would be clinically beneficial to investigate the mechanisms of sensitization associated with acute inflammation.
Several types of voltage-dependent Ca channels are known to be expressed in nociceptive neurons. 6
Especially, N- and P/Q-type channels are highly expressed in primary sensory neurons 7,8
and the spinal cord. 9
These channels have been demonstrated to be responsible for the release of nociceptive neurotransmitters, such as glutamate, calcitonin gene–related peptide, and substance P, from primary sensory neurons. 10,11
Behavioral and in vivo
electrophysiologic experiments have revealed that N- and P/Q-type channel blockers have analgesic effects on several kinds of pain. 6
In the models of acute inflammatory pain, for instance, spinal administration of ω-conotoxin GVIA (GVIA), an N-type channel blocker, reduced the spinal neuronal responses to innocuous or noxious pressure applied to either a knee that was inflamed by kaolin and carrageenan (primary hyperalgesia and allodynia) or a noninflamed ankle ipsilateral to the inflamed knee (secondary hyperalgesia and allodynia) in anesthetized rats. 12
Spinal administration of a P/Q-type channel blocker, ω-agatoxin IVA (AgaIVA), also depressed the primary hyperalgesia and allodynia without effects on the secondary hyperalgesia and allodynia. 13
Thus, it is expected that voltage-dependent Ca channel blockers may also have some inhibitory effects on the hypersensitization.
In this study, we tested the hypothesis that voltage-dependent Ca channels contribute to the hypersensitization after acute inflammation. First, we assessed the presence of long-lasting allodynia as an increased sensitivity to inflammatory mediators. Next, we investigated the effect of intrathecal administration of N- and P/Q-type channel blockers on this allodynia. Finally, we evaluated the possible plastic change of N-type channel expression in dorsal root ganglia (DRGs) and the spinal cord of rats in this sensitized state. In addition, we used the heterozygous alleles of N-type channel knockout (Cav
2.2 +/−) mice 14
to investigate the change of spinal expression of the N-type channel to supplement the experiment in rats.
Materials and Methods
All experiments were conducted under the ethical guidelines for the study of experimental pain in conscious animals, 15
and the protocol of the pain behavioral studies described here was approved by the Animal Care Committee of Tokyo Medical and Dental University.
We used male Sprague–Dawley rats weighing 250–300 g (Japan Clea, Sizuoka, Japan) for behavioral and immunoblot analysis and heterozygous alleles of N-type channel knockout (Cav
2.2 +/−) mice 14
weighing 28–35 g for 5-bromo-4-chloro-3-indolyl β-d-galactopyranoside (X-Gal) staining. The animals were housed in a temperature- and humidity-controlled environment with a 12-h light–dark cycle and free access to food and water.
The current study used a recently introduced experimental system with some modification. In the original study, long-lasting hypersensitivity to proinflammatory mediators (100 ng/5 μl prostaglandin E2
]) after the resolution of carrageenan (1%; 5 μl)–induced acute inflammation was evaluated by the Randall–Selitto test for the nociceptive flexion reflex. 16
In our preliminary study, however, it was difficult to detect reproducible mechanical hypersensitivity under a similar condition. Therefore, we used greater amounts of carrageenan (2%; 100 μl) and PGE2
(400 ng/20 μl) and evaluated a long-lasting mechanical hypersensitivity using von Frey hairs (Stoelting Company, Wood Dale, IL). Carrageenan is a classic agent causing experimental inflammation, and the induced inflammatory pain is considered relevant to clinically important inflammatory pain states. 17,18
is one of the best-characterized proinflammatory mediators known to be present in increased concentration at sites of inflammation and is shown to induce hyperalgesia and allodynia by a direct action on primary afferent nociceptors. 1,2,19
All behavioral experiments were performed in a soundproof room during the light cycle (7:00 am to 7:00 pm). Rats were acclimatized to the experimental room for at least 1 h before the experiments.
Tactile allodynia was evaluated with calibrated von Frey hairs by measuring the tactile stimulus producing a 50% likelihood of a withdrawal response (50% gram threshold), which was calculated by using the up–down paradigm of Dixon as described in detail before. 20
A stimulus strength of 15.1 g was adopted as the upper limit of testing.
Pharmacology and Drug Administration
All subcutaneous and intrathecal injections were performed using a 30-gauge needle during a few minutes of anesthetization with halothane, 2% (Takeda Chemical Industries, Ltd., Osaka, Japan). In this study, rats and the Cav
2.2 +/− mice received a solution, 2%, of λ-carrageenan (Sigma Chemical Company, St. Louis, MO) in saline in the plantar surface of the hind paw (100 μl for rats and 20 μl for mice). The injection side was selected randomly. Control experiments were conducted by injection of the same volume of physiologic saline solution. Seven days after carrageenan or saline injection, rats received either GVIA (0.03, 0.1, or 0.3 μg) or AgaIVA (0.01, 0.03, or 0.1 μg) intrathecally in a total volume of 10 μl 30 min before PGE2
injection (400 ng/20 μl) into the pretreated plantar surface of the hind paw. Each animal received no more than a single dose of the Ca channel blockers. Saline (10 μl) was administered intrathecally in the control experiments. Although the effects of GVIA were known to be relatively slow in onset, 21
this interval was sufficient to establish maximal inhibitory effects of GVIA in our preliminary study.
AgaIVA and GVIA (Peptide Institute, Inc., Osaka, Japan) and PGE2
(Cayman Chemical Company, Ann Arbor, MI) were made up as concentrated stock solutions in MilliQ water (Nihon Millipore, Tokyo, Japan) or 10% ethanol in saline for PGE2
, divided into aliquots, and stored at −20°C. Aliquots were thawed and diluted to the desired concentrations in saline immediately before use. The doses of these drugs were determined according to previous studies 22–25
and our preliminary study.
Rats were deeply anesthetized with intraperitoneal sodium pentobarbital (45 mg/kg) at 7 days after carrageenan or saline injections, and L4–L6 DRGs (ipsilateral to the injections) or the spinal cord was dissected. After dissection, rats were killed by further injection of excess doses of sodium pentobarbital (100 mg/kg). Pooled DRGs from at least eight rats were homogenized in 700 μl lysis buffer, pH 8.0, containing 150 mm NaCl, 1 mm EDTA, and protease inhibitors (0.2 mm phenylmethylsulfonyl fluoride, 1 μg/ml aprotinin, 1 μg/ml pepstatin A, 1 μg/ml leupeptin, 0.1 mg/ml benzamidine). The 100,000 g membrane fraction was dissolved in sample buffer (10 mm Tris/HCl, pH 6.8, containing 0.005% Coomassie brilliant blue-G, 1.5% sodium dodecyl sulfate, 2 m urea, and 10 mm dithiothreitol), and the proteins (150 μg per lane) were resolved on a 5% polyacrylamide gel. Protein concentrations were determined with a protein assay kit (Bio-Rad Laboratories, Hercules, CA). The proteins were transferred onto a polyvinylidene difluoride membrane (Immobilon P; Millipore, Billerica, MA), and the blot was probed with a rabbit polyclonal anti-α1B antibody (Exalpha Biologicals, Watertown, MA) by using the ECL system (Amersham Bioscience, Piscataway, NJ). The N-type channel protein levels from seven independent experiments using four different pooled samples were quantified using the analysis software NIH image 1.62 (National Institutes of Health, Bethesda, MD). After immunoblotting, the membranes were stained with SYPRO Orange (Molecular Probes, Eugene, OR) and scanned with a FluorImager 595 (Molecular Dynamics, Sunnyvale, CA), and the total transferred proteins were quantified with IMAGE QUANT software (Molecular Dynamics) to normalize the N-type channel protein band intensities.
For each set of experiments, the normalized band intensity of the saline control sample was set as 100, and then the ratio of the normalized band intensity of the carrageenan-treated sample to the saline control sample was calculated. For negative controls, antibody was excluded or incubated with α1B antigen peptide (Alomone Laboratories, Jerusalem, Israel).
Seven days after carrageenan injection, Cav
2.2 +/− mice were anesthetized with sodium pentobarbital and subjected to fixation by transcardial perfusion with paraformaldehyde, 4%, in phosphate-buffered saline. X-Gal staining was performed on spinal cord sections as reported previously. 26
Briefly, after perfusion fixation, the spinal cord was dissected, rinsed with phosphate-buffered saline, and then stained with X-Gal solution (Sigma Chemical Company). Because the gene for Escherichia coli
β-galactosidase with a nuclear localization signal was inserted in frame in the N-type channel gene cacna 1b
, the β-gal activity monitored by X-Gal staining is considered to represent the native expression of the gene encoding the N-type channel. 14
Nuclear localization is useful for excluding the contribution of the channel protein, which exists on the terminals of primary sensory neurons. Thus, this method is more advantageous than immunoblot analysis using dissected spinal cord samples, which inevitably include the central terminal component of primary sensory neurons. The levels of staining intensity in the spinal dorsal horn were quantified with NIH image and calculated as the ratio of the carrageenan-treated side to the contralateral side.
Experimental data in the figures are mean ± SEM. The immunoblot and X-Gal staining data were tested according to the Student t test. For behavioral analyses, we used the Mann–Whitney U test for comparisons between two groups and the Steel–Dwass test for multiple comparisons. P < 0.05 was considered statistically significant.
PGE2 Induced Long-lasting Allodynia after Carrageenan Preconditioning
We observed that a 100-μl carrageenan (2%) challenge resulted in swelling, erythema, and reduced threshold of paw withdrawal to mechanical stimuli with von Frey filaments in rats. These alterations began 30–60 min after injection, reaching a maximum in 2–4 h, and resolved within 3 to 4 days. Consistent with findings of numerous previous reports, this routinely used dose of carrageenan 27,28
produced only short-term hyperalgesia and allodynia from which the rats could fully recover.
Intradermal injection of PGE2
at the same site where carrageenan had been injected 7 days earlier resulted in a prolonged mechanical allodynia lasting more than 4 h (fig. 1
). In contrast, PGE2
produced only transient allodynia lasting less than 1 h (acute allodynia) in saline-injected control rats (fig. 1
). Furthermore, the mean values of 50% thresholds of the early (30 min) and late (4 h) phases of PGE2
-induced allodynia in carrageenan-preconditioned rats were significantly lower than those for their respective control derived from saline-preconditioned rats (fig. 1
injection into the carrageenan-preconditioned paw also evoked long-lasting allodynia in the contralateral hind paw (“mirror-image” pain), although the mean values of 50% thresholds were less marked (fig. 2
). The 50% threshold values between early and late phases of the PGE2
-evoked allodynia were not different on ipsilateral and contralateral sides, respectively. There was no allodynia in the contralateral hind paw of saline-preconditioned rats.
Intrathecal Injection of GVIA Reduced the PGE2-induced Long-lasting Allodynia
In saline-preconditioned rats, the PGE2
-induced acute allodynia was significantly attenuated by GVIA at the lowest dose used in this study (0.03 μg) and almost completely blocked at 0.1 μg (fig. 2A
). In carrageenan-preconditioned rats, however, the early and late phases of PGE2
-induced allodynia were not significantly affected by 0.03 μg GVIA, and greater than 0.1 μg GVIA was required to achieve significant inhibition of both allodynia phases (fig. 2A and B
The early and late phases of PGE2
-induced allodynia observed in the contralateral hind paws were almost completely blocked by lower doses of GVIA (fig. 2C and D
). At the GVIA doses used in this study, rats behaved apparently normal, and we did not observe any aversive responses reported for this toxin. 22
Intrathecal Injection of AgaIVA Had No Effects on the PGE2-induced Allodynia
To test whether the P/Q-type channel was also involved in this long-lasting allodynia, we investigated the effects of intrathecal injection of AgaIVA on this PGE2
-induced long-lasting allodynia. As shown in figure 3A and B
, AgaIVA did not attenuate PGE2
-induced prolonged ipsilateral allodynia at both time points. AgaIVA also had no effects on the contralateral allodynia at 0.01 and 0.03 μg (fig. 3C and D
). At 0.1 μg, however, AgaIVA significantly enhanced the early, but not the late, phase of the contralateral allodynia (fig. 3C and D
-induced acute allodynia in saline-preconditioned rats was also significantly potentiated at 0.1 μg (fig. 3A
). We did not increase the dose of AgaIVA to greater than 0.1 μg, because higher doses induced some anomalous neurologic behaviors (sudden intense irritation and agitation behaviors against environmental stimuli including von Frey stimulation). 22
N-type Channel Expression Was Enhanced after Carrageenan Inflammation
We studied possible changes in the level of the N-type channel in the DRG and spinal dorsal horn after carrageenan inflammation. By quantitative Western blotting, we found that the normalized expression level of N-type channel protein in the DRGs from carrageenan-preconditioned rats was significantly higher than that of saline controls (fig. 4
). Although we tried hard to quantify the N-type channel protein expression in L4–L6 spinal cord sections from these animals, in many cases, we could not detect the channel protein.
It has been suggested previously that both rats and mice have a similar time course for carrageenan-induced acute inflammation and hyperalgesia. 29
We confirmed that both wild-type and Cav
2.2 +/− mice have the acute inflammatory pain behavior similar to that in rats (unpublished data, K. Yokoyama, M.D., T. Kurihara, Ph.D., and T. Tanabe, Ph.D., Tokyo, Japan [June 4, 2003]). Thus, we investigated the expression level of the N-type channel in the spinal cord of Cav
2.2 +/− mice, preconditioned by carrageenan 7 days ago, as the β-galactosidase activity monitored by X-Gal staining. X-Gal staining revealed a broad expression of the N-type channel throughout the spinal gray matter, particularly in the dorsal horn (fig. 5A
), which is generally consistent with findings of a previously reported immunohistochemical study. 9
The expression level of the channel protein ipsilateral to the carrageenan-preconditioned paw was significantly higher than that of the contralateral side (fig. 5B
To our knowledge, this is the first behavioral and biochemical study addressing the plastic nature of N-type channel expression in a latent hypersensitization state after acute inflammation. Our results are in line with the hypothesis that the up-regulation of the N-type channel in DRGs and the spinal dorsal horn is a cause of the long-lasting hypersensitivity to an inflammatory mediator.
The up-regulation of channel proteins in DRGs or the spinal cord after experimental short-term inflammation has not been reported before. However, the up-regulation of P/Q-type, but not N- or L-type, channel protein has been shown in the trigeminal ganglion after tooth pulp inflammation. 30
In the peripheral nerve injury/neuropathic pain models, the up-regulation of N-type channel protein in the spinal cord after chronic constrictive nerve injury has been reported 31
; on the other hand, no change of N-type channel expression in the spinal cord after spinal nerve injury 32
and injured DRGs at the mRNA level 32–34
has been demonstrated. A previous electrophysiologic study showed that densities of high-voltage-activated Ca2+
currents in DRG neurons were reduced by the peripheral nerve injuries. 8,35,36
In the current study, we could not detect N-type channel expression constantly in the rat spinal cord by Western blotting. This might be partly due to a much lower basal expression of the channel protein in the spinal cord than in the DRG. 32
The study of N-type channel expression in the Cav
2.2 +/− mice spinal cord, although the possibility of species differences could not be completely eliminated, further suggested the plastic nature and importance of this channel in a latent hypersensitization state.
Another important finding of this study was that the carrageenan-conditioning stimulus could induce PGE2
-evoked prolonged allodynia not only in the conditioned hind paw but also in the contralateral (noninflamed) hind paw. This result is consistent with previous findings of recurrent inflammation 4,5
and neuropathic pain models. 37,38
A recent study suggested the role of spinal glia and proinflammatory cytokines in “mirror-image (contralateral)” neuropathic pain. 39
Although the precise mechanism causing pain on the contralateral side remains to be explored, our results may suggest that the spinal N-type channel is involved in “mirror-image” pain.
It has been reported that the activation of protein kinase Cε in the sensitized peripheral neurons might be involved in this long-lasting hypersensitivity. 16
Another recent report suggested a possible functional link between protein kinase Cε activation and N-type channel up-regulation. 40
There is evidence indicating that protein kinase Cε is one of the major protein kinase C isozymes expressed in sensory neurons and is important for nociceptor regulation. 41,42
Therefore, an increase or decrease of some factors in inflamed hind paw and spinal cord during acute inflammation would eventually enhance the activity of protein kinase Cε, leading to the up-regulation of the N-type channel.
Recently, several N-type channel blockers have been developed as promising analgesics for a variety of pain conditions. 43
In particular, ziconotide (a synthetic form of ω-conotoxin MVIIA) has been evaluated in a number of clinical trials (mainly for neuropathic and cancer pain) via
intrathecal administration. Although ziconotide is generally tolerated, it has been reported to produce significant adverse effects such as bradycardia, nausea, ataxia, and so on. 44
Recently, CVID, a more selective N-type channel blocker, was shown to have a wider therapeutic window than ω-conotoxin MVIIA in the treatment of a chronic inflammatory pain 45
(adjuvant-induced mechanical hyperalgesia). Our results suggest that the efficacy of N-type channel blockers might be reduced in the chronic inflammatory pain conditions preceded by the acute inflammation. In this context, we showed recently that the induction level of VDCC α2
δ subunit expression might determine the sensitivity of gabapentin analgesia among the different neuropathic pain models. 34
In contrast to the N-type channel blocker, the P/Q-type channel blocker had no inhibitory actions on any type of the PGE2
-induced allodynia. At the highest dose in this study, AgaIVA rather exerted stimulatory actions on the contralateral allodynia in carrageenan-conditioned rats and the acute allodynia in saline-conditioned rats. The doses used in this study (0.01–0.1 μg: roughly corresponding to 2–20 pmol) appear to be within the commonly used range. Malmberg and Yaksh 22
showed that less than 10 pmol of intrathecal AgaIVA had potent inhibitory effects of formalin-induced nociceptive behavior. Sluka 23,24
demonstrated that intraspinal preadministration of AgaIVA within the similar range reduced the secondary hyperalgesic and allodynic behavior induced by intradermal capsaicin or acute joint inflammation. Thus, the P/Q-type channel plays a role in spinal pain transmission but does not seem to be involved in the allodynia induced by PGE2
administration. Although the reason for a lack of antiallodynic action of AgaIVA is not known at present, the stimulatory effect is partly consistent with the observations suggesting that the P/Q-type channel is preferentially involved in inhibitory neurotransmission in the spinal dorsal horn in the normal state. 6,13
In summary, PGE2 produced prolonged mechanical allodynia in both hind paws (more prominent on the ipsilateral side) after apparent resolution of unilateral carrageenan-induced acute inflammation. On the other hand, PGE2 induced only short-lasting mechanical allodynia in saline-preconditioned paws of control rats. An N-type channel blocker, GVIA, but not a P/Q-type channel blocker, AgaIVA, inhibited PGE2-induced allodynia. High doses of GVIA were necessary in carrageenan-preconditioned rats, which might be caused by the up-regulation of N-type channel expression in DRGs and the spinal cord ipsilateral to the carrageenan pretreatment. Thus, clarifying the mechanism of up-regulation of N-type channel protein would be important as a future study.
The authors are grateful to Z. David Luo, M.D., Ph.D. (Assistant Professor, Department of Anesthesiology, University of California, San Diego, CA), for his helpful advice on Western blotting and Hironao Saegusa, Ph.D., and Yoshihiro Matsuda, Ph.D. (Department of Pharmacology and Neurobiology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan), for providing useful suggestions on X-gal staining.
1. Kidd BL, Urban LA: Mechanisms of inflammatory pain. Br J Anaesth 2001; 87: 3–11
2. Levine JD, Reichling DB: Peripheral mechanisms of inflammatory pain, Textbook of Pain, 4th edition. Edited by Wall PD, Melzack R. London, Churchill Livingstone, 1999, pp 59–84
3. Woolf CJ, Salter MW: Neuronal plasticity: Increasing the gain in pain. Science 2000; 288: 1765–72
4. Kayser V, Idanpaan-Heikkila JJ, Guilbaud G: Sensitization of the nervous system, induced by two successive hindpaw inflammations, is suppressed by a local anesthetic. Brain Res 1998; 794: 19–27
5. Perrot S, Guilbaud G, Kayser V: Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation. A nesthesiology 2001; 94: 870–5
6. Vanegas H, Schaible H-G: Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 2000; 85: 9–18
7. Scroggs R, Fox AP: Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size. J Physiol (Lond) 1992; 445: 639–58
8. Baccei ML, Kocsis JD: Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons. J Neurophysiol 2000; 83: 2227–38
9. Westenbroek RE, Hoskins L, Catterall WA: Localization of Ca2+
channel subtypes on rat motor neurons, interneurons, and nerve terminals. J Neurosci 1998; 18: 6319–30
10. Santicioli P, Del Bianco E, Tramontana M, Geppetti P, Maggi CA: Release of calcitonin gene-related peptide like-immunoreactivity induced by electrical field stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels. Neurosci Lett 1992; 136: 161–4
11. Hong WK, Kim CD, Rhim BY, Lee WS: Effect of omega-conotoxin GVIA and omega-agatoxin IVA on the capsaicin-sensitive calcitonin gene-related peptide release and autoregulatory vasodilation in rat pial arteries. J Cereb Blood Flow Metab 1999; 19: 53–60
12. Neugebauer V, Vanegas H, Nebe J, Rümenapp P, Schaible H-G: Effects of N- and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and the inflamed knee joint. J Neurophysiol 1996; 76: 3740–9
13. Nebe J, Vanegas H, Neugebauer V, Schaible H-G: Omega-agatoxin IVA, a P-type calcium channel antagonist, reduces nociceptive processing in spinal cord neurons with input from the inflamed but not from the normal knee joint: An electrophysiological study in the rat in vivo. Eur J Neurosci 1997; 9: 2193–201
14. Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T, Han W, Toriyama H, Tanabe T: Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+
channel. EMBO J 2001; 20: 2349–56
15. International Association for the Study of Pain. Animal models of pain and ethics of animal experimentation, Core Curriculum for Professional Education in Pain. Edited by Fields HL. Seattle, IASP Press, 1995, pp 111–2
16. Aley KO, Messing RO, Mochly-Roson D, Levine JD: Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the ε isozyme of protein kinase C. J Neurosci 2000; 20: 4680–5
17. Di Rosa M: Biological properties of carrageenan. J Pharm Pharmacol 1972; 24: 89–102
18. Levy L: Carrageenan paw oedema in the mouse. Life Sci 1969; 8: 601–6
19. Ito S, Okuda-Ashitaka E, Minami T: Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 2001; 41: 299–332
20. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55–63
21. Pin JP, Bockaert J: Omega-conotoxin GVIA and dihydropyridine discriminate two types of Ca2+
channels involved in GABA release from striatal neurons in culture. Eur J Pharmacol 1990; 188: 81–4
22. Malmberg AB, Yaksh TL: Voltage-sensitive calcium channels in spinal nociceptive processing: Blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci 1994; 14: 4882–90
23. Sluka KA: Blockade of calcium channels can prevent the onset of secondary hyperalgesia and allodynia induced by intradermal injection of capsaicin in rats. Pain 1997; 71: 157–64
24. Sluka KA: Blockade of N-type and P/Q-type calcium channels reduces the secondary heat hyperalgesia induced by acute inflammation. J Pharmacol Exp Ther 1998; 287: 232–7
25. Matthews EA, Dickenson AH: Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001; 92: 235–46
26. Saegusa H, Kurihara T, Zong S, Minowa O, Kazuno A, Han W, Matsuda Y, Yamanaka H, Osanai M, Noda T, Tanabe T: Altered pain responses in mice lacking α1E
subunit of the voltage-dependent Ca2+
channel. Proc Natl Acad Sci USA 2000; 97: 6132–7
27. Diring DM, Isakson PC, Yaksh TL: Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 1998; 285: 1031–8
28. Yamamoto T, Nozaki-Taguchi N: Role of spinal cyclooxygenase (COX)-2 on thermal hyperalgesia evoked by carrageenan injection in the rat. Neuroreport 1997; 8: 2179–82
29. Sammons MJ, Raval P, Davey PT, Rogers D, Parsons AA, Bingham S: Carrageenan-induced thermal hyperalgesia in the mouse: Role of nerve growth factor and the mitogen-activated protein kinase pathway. Brain Res 2000; 876: 48–54
30. Westenbroek RE, Byers MR: Up-regulation of class A Ca2+
channels in trigeminal ganglion after pulp exposure. Neuroreport 1999; 10: 381–5
31. Cizkova D, Marsala J, Lukacova N, Marsala M, Jergova S, Orendacova J, Yaksh TL: Localization of N-type Ca2+
channels in the rat spinal cord following chronic constrictive nerve injury. Exp Brain Res 2002; 147: 456–63
32. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL: Upregulation of dorsal root ganglion α2δ
calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001; 21: 1868–75
33. Kim D-S, Yoon C-H, Lee YS-J, Park S-Y, Yoo H-J, Cho H-J: Changes in voltage-gated calcium channel α1 gene expression in rat dorsal root ganglia following peripheral nerve injury. Mol Brain Res 2001; 96: 151–6
34. Abe M, Kurihara T, Han W, Shinomiya K, Tanabe T: Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain. Spine 2002; 27: 1517–25
35. Abdulla FA, Smith PA: Axotomy- and autotomy-induced changes in Ca2+
channel currents of rat dorsal root ganglion neurons. J Neurophysiol 2001; 85: 644–58
36. Hogan QH, McCallum JB, Sarantopoulos C, Aason M, Mynlieff M, Kwok W-M, Bosnjak ZJ: Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons. Pain 2000; 86: 43–53
37. Seltzer Z, Dubner R, Shir Y: A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990; 43: 205–18
38. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50: 355–63
39. Milligan ED, Twinging C, Chacur M, Biedenkap J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR: Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003; 23: 1026–40
40. McMahon T, Andersen R, Metten P, Crabbe JC, Messing RO: Protein kinase C ε mediates up-regulation of N-type calcium channels by ethanol. Mol Pharmacol 2000; 57: 53–8
41. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA: Specific involvement of PKC-ε in the sensitization of the neuronal response to painful heat. Neuron 1999; 23: 617–24
42. Khasar SC, Lin Y-H, Martin A, Dadgar J, McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD, Messing RO: A novel nociceptor signaling pathway revealed in protein kinase C ε mutant mice. Neuron 1999; 24: 253–60
43. Snutch TP, Sutton KG, Zamponi GW: Voltage-dependent calcium channels: Beyond dihydropyridine antagonists. Curr Opin Pharmacol 2001; 1: 11–6
44. Penn RD, Paice JA: Adverse effects associated with the intrathecal administration of ziconotide. Pain 2000; 85: 291–6
45. Smith MT, Cabot PJ, Ross FB, Robertoson AD, Lewis RJ: The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002; 96: 119–27
This article has been cited 1 time(s).
Marine DrugsOmega-Conotoxins as Experimental Tools and Therapeutics in Pain ManagementMarine Drugs
© 2003 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.